Brain gain: the underground world of neuroenhancing drugs.
Talbot
Margaret
M
New America Foundation.
D000293:Adolescent; D000328:Adult; D000368:Aged; D019969:Amphetamine-Related Disorders / Q000145:classification / Q000175:diagnosis / Q000191:economics / Q000453:epidemiology / Q000266:history / Q000523:psychology; D001289:Attention Deficit Disorder with Hyperactivity / Q000266:history; D024803:Biomedical Enhancement / Q000191:economics* / Q000941:ethics* / Q000266:history* / Q000379:methods*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000009:adverse effects / Q000134:cerebrospinal fluid / Q000145:classification / Q000191:economics* / Q000266:history* / Q000494:pharmacology / Q000592:standards / Q000600:supply & distribution / Q000627:therapeutic use*; D003071:Cognition / Q000145:classification / Q000187:drug effects* / Q000941:ethics*; D003405:Creativity; D015259:Dopamine Agents / Q000266:history / Q000493:pharmacokinetics / Q000627:therapeutic use; D004992:Ethics, Medical / Q000266:history; D005715:Gambling / Q000523:psychology; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D008875:Middle Aged; D009446:Neurobiology / Q000266:history / Q000639:trends; D013334:Students / Q000266:history / Q000523:psychology; D013647:Task Performance and Analysis; D055815:Young Adult
D000697:Central Nervous System Stimulants; D015259:Dopamine Agents